Mary L Vance, MD | |
415 Ray C. Hunt Drive, Ste 2100, Charlottesville, VA 22903 | |
(434) 982-3591 | |
(434) 924-5894 |
Full Name | Mary L Vance |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 47 Years |
Location | 415 Ray C. Hunt Drive, Charlottesville, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497898050 | NPI | - | NPPES |
006045634 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101033140 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Virginia Medical Center | Charlottesville, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
In a letter sent to Congressional members on August 14, the Electronic Cigarette Association (ECA) criticized the recent Food and Drug Administration (FDA) study on electronic cigarettes as it failed to follow standard scientific protocols and was too narrow in scope. In addition, the letter called on Congress to enact legislation that would make it illegal to sell electronic cigarettes to those below the legal age of smoking.
Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.
A Google search using the key words "snoring" and "treatment" yielded over 5 million results, but no standard treatment is available for primary snoring or snoring associated with a mild form of obstructive sleep apnea (OSA).
Efforts to effectively control pain in hospitalized patients with opioid (narcotic) analgesics can lead to unintentional sedation and respiratory depression, which are serious adverse events affecting the quality of recovery for patients.
Using advanced technologies for rapidly sequencing and analyzing DNA from clinical and pathologic samples, a multidisciplinary research team consisting of geneticists, pathologists and surgeons at Boston Children's Hospital has identified the genetic basis for CLOVES syndrome, a rare congenital malformation and overgrowth disorder.
› Verified 2 days ago
Entity Name | University Of Virginia Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
In a letter sent to Congressional members on August 14, the Electronic Cigarette Association (ECA) criticized the recent Food and Drug Administration (FDA) study on electronic cigarettes as it failed to follow standard scientific protocols and was too narrow in scope. In addition, the letter called on Congress to enact legislation that would make it illegal to sell electronic cigarettes to those below the legal age of smoking.
Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.
A Google search using the key words "snoring" and "treatment" yielded over 5 million results, but no standard treatment is available for primary snoring or snoring associated with a mild form of obstructive sleep apnea (OSA).
Efforts to effectively control pain in hospitalized patients with opioid (narcotic) analgesics can lead to unintentional sedation and respiratory depression, which are serious adverse events affecting the quality of recovery for patients.
Using advanced technologies for rapidly sequencing and analyzing DNA from clinical and pathologic samples, a multidisciplinary research team consisting of geneticists, pathologists and surgeons at Boston Children's Hospital has identified the genetic basis for CLOVES syndrome, a rare congenital malformation and overgrowth disorder.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mary L Vance, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Mary L Vance, MD 415 Ray C. Hunt Drive, Ste 2100, Charlottesville, VA 22903 Ph: (434) 982-3591 |
News Archive
In a letter sent to Congressional members on August 14, the Electronic Cigarette Association (ECA) criticized the recent Food and Drug Administration (FDA) study on electronic cigarettes as it failed to follow standard scientific protocols and was too narrow in scope. In addition, the letter called on Congress to enact legislation that would make it illegal to sell electronic cigarettes to those below the legal age of smoking.
Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.
A Google search using the key words "snoring" and "treatment" yielded over 5 million results, but no standard treatment is available for primary snoring or snoring associated with a mild form of obstructive sleep apnea (OSA).
Efforts to effectively control pain in hospitalized patients with opioid (narcotic) analgesics can lead to unintentional sedation and respiratory depression, which are serious adverse events affecting the quality of recovery for patients.
Using advanced technologies for rapidly sequencing and analyzing DNA from clinical and pathologic samples, a multidisciplinary research team consisting of geneticists, pathologists and surgeons at Boston Children's Hospital has identified the genetic basis for CLOVES syndrome, a rare congenital malformation and overgrowth disorder.
› Verified 2 days ago
Daniel S. Strand, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-243-5233 Fax: 434-244-7526 | |
Dr. Numaan F. Malik, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Lee St Fl 2, Charlottesville, VA 22908 Phone: 434-924-5219 Fax: 434-924-9720 | |
Dr. Asma Shahid Habib, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-9119 Fax: 434-924-3300 | |
Amber N. Inofuentes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-4288 Fax: 434-243-7310 | |
Mark Thomas Worthington, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-3090 Fax: 434-244-9445 | |
Dr. Emanuel Cirenza, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 590 Peter Jefferson Place, Suite 175, Charlottesville, VA 22911 Phone: 434-982-6900 Fax: 434-982-8420 | |
Warren K. Bolton, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-1984 Fax: 434-924-5898 |